Opexa Therapeutics, Inc. (OPXA) Reports Q1 Loss of $0.13

Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q1 EPS of ($0.13), versus ($0.58) reported last year. Revenue for the quarter came in at $348.8 thousand, versus $220.1 thousand reported last year.

For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c